Teva Releases Q3 2026 Aide Memoire

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2026 Aide Memoire is available on the “Investors” page on its website. Q3 2026 Aide Memoire Teva has compiled this document with public information that was previously provided by Teva […]